These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Biochemical (prostate specific antigen) recurrence probability following radical prostatectomy for clinically localized prostate cancer. Han M, Partin AW, Zahurak M, Piantadosi S, Epstein JI, Walsh PC. J Urol; 2003 Feb; 169(2):517-23. PubMed ID: 12544300 [Abstract] [Full Text] [Related]
6. Preoperative PSA level significantly associated with interval to biochemical progression after radical retropubic prostatectomy. Gonzalez CM, Roehl KA, Antenor JV, Blunt LW, Han M, Catalona WJ. Urology; 2004 Oct; 64(4):723-8. PubMed ID: 15491709 [Abstract] [Full Text] [Related]
7. Identification of factors predicting response to adjuvant radiation therapy in patients with positive margins after radical prostatectomy. Kamat AM, Babaian K, Cheung MR, Naya Y, Huang SH, Kuban D, Babaian RJ. J Urol; 2003 Nov; 170(5):1860-3. PubMed ID: 14532793 [Abstract] [Full Text] [Related]
8. Risk factors of positive surgical margin and biochemical recurrence of patients treated with radical prostatectomy: a single-center 10-year report. Li K, Li H, Yang Y, Ian LH, Pun WH, Ho SF. Chin Med J (Engl); 2011 Apr; 124(7):1001-5. PubMed ID: 21542957 [Abstract] [Full Text] [Related]
9. The significance of positive surgical margin in areas of capsular incision in otherwise organ confined disease at radical prostatectomy. Chuang AY, Nielsen ME, Hernandez DJ, Walsh PC, Epstein JI. J Urol; 2007 Oct; 178(4 Pt 1):1306-10. PubMed ID: 17698141 [Abstract] [Full Text] [Related]
10. Do margins matter? The prognostic significance of positive surgical margins in radical prostatectomy specimens. Swindle P, Eastham JA, Ohori M, Kattan MW, Wheeler T, Maru N, Slawin K, Scardino PT. J Urol; 2005 Sep; 174(3):903-7. PubMed ID: 16093984 [Abstract] [Full Text] [Related]
11. Outcome and complications of radical prostatectomy in patients with PSA <10 ng/ml: comparison between the retropubic, perineal and laparoscopic approach. Salomon L, Levrel O, Anastasiadis AG, Saint F, de La Taille A, Cicco A, Vordos D, Hoznek A, Chopin D, Abbou CC. Prostate Cancer Prostatic Dis; 2002 Sep; 5(4):285-90. PubMed ID: 12627213 [Abstract] [Full Text] [Related]
12. Subclassification of clinical stage T1 prostate cancer: impact on biochemical recurrence following radical prostatectomy. Magheli A, Rais-Bahrami S, Carter HB, Peck HJ, Epstein JI, Gonzalgo ML. J Urol; 2007 Oct; 178(4 Pt 1):1277-80; discussion 1280-1. PubMed ID: 17698121 [Abstract] [Full Text] [Related]
13. Long-term outcome after radical prostatectomy for patients with lymph node positive prostate cancer in the prostate specific antigen era. Boorjian SA, Thompson RH, Siddiqui S, Bagniewski S, Bergstralh EJ, Karnes RJ, Frank I, Blute ML. J Urol; 2007 Sep; 178(3 Pt 1):864-70; discussion 870-1. PubMed ID: 17631342 [Abstract] [Full Text] [Related]
14. Vascular invasion predicts recurrence after radical prostatectomy: stratification of risk based on pathologic variables. Ferrari MK, McNeal JE, Malhotra SM, Brooks JD. Urology; 2004 Oct; 64(4):749-53. PubMed ID: 15491714 [Abstract] [Full Text] [Related]
15. Impact of patient age on biochemical recurrence rates following radical prostatectomy. Magheli A, Rais-Bahrami S, Humphreys EB, Peck HJ, Trock BJ, Gonzalgo ML. J Urol; 2007 Nov; 178(5):1933-7; discussion 1937-8. PubMed ID: 17868723 [Abstract] [Full Text] [Related]
16. The relationship between the extent of surgical margin positivity and prostate specific antigen recurrence in radical prostatectomy specimens. Marks RA, Koch MO, Lopez-Beltran A, Montironi R, Juliar BE, Cheng L. Hum Pathol; 2007 Aug; 38(8):1207-11. PubMed ID: 17490720 [Abstract] [Full Text] [Related]
17. Radical prostatectomy for incidental (stage T1a-T1b) prostate cancer: analysis of predictors for residual disease and biochemical recurrence. Capitanio U, Scattoni V, Freschi M, Briganti A, Salonia A, Gallina A, Colombo R, Karakiewicz PI, Rigatti P, Montorsi F. Eur Urol; 2008 Jul; 54(1):118-25. PubMed ID: 18314255 [Abstract] [Full Text] [Related]
18. No difference in six-year biochemical failure rates with or without pelvic lymph node dissection during radical prostatectomy in low-risk patients with localized prostate cancer. Bhatta-Dhar N, Reuther AM, Zippe C, Klein EA. Urology; 2004 Mar; 63(3):528-31. PubMed ID: 15028451 [Abstract] [Full Text] [Related]
19. The actual value of the surgical margin status as a predictor of disease progression in men with early prostate cancer. Vis AN, Schröder FH, van der Kwast TH. Eur Urol; 2006 Aug; 50(2):258-65. PubMed ID: 16413660 [Abstract] [Full Text] [Related]
20. Incidence, etiology, location, prevention and treatment of positive surgical margins after radical prostatectomy for prostate cancer. Wieder JA, Soloway MS. J Urol; 1998 Aug; 160(2):299-315. PubMed ID: 9679867 [Abstract] [Full Text] [Related] Page: [Next] [New Search]